BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 2877483)

  • 1. [Prevention of arrhythmia in myocardial infarct (secondary prevention)].
    Gertsch M
    Schweiz Rundsch Med Prax; 1986 Sep; 75(40):1181-7. PubMed ID: 2877483
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of antiarrhythmic drugs in prevention of sudden cardiac death.
    Podrid PJ
    Cardiovasc Clin; 1985; 15(3):265-86. PubMed ID: 2421903
    [No Abstract]   [Full Text] [Related]  

  • 3. [Stratification of arrhythmia risk and therapeutic options in survivors of acute myocardial infarction].
    Arós Borau F; Loma-Osorio A; Torres Bosco A
    Rev Esp Cardiol; 1996 Mar; 49(3):157-65. PubMed ID: 8685518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Betablockers, anti-arrhythmia and anti-ischemia agents and other drugs ... in the follow-up of myocardial infarction].
    Coumel P
    Arch Mal Coeur Vaiss; 1990 Sep; 83(10):1497-9. PubMed ID: 1978650
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prevention of sudden death with antiarrhythmic agents after myocardial infarction].
    Raviele A; Gasparini G
    G Ital Cardiol; 1992 Apr; 22(4):463-7. PubMed ID: 1385246
    [No Abstract]   [Full Text] [Related]  

  • 6. [Secondary prevention of myocardial infarct with anti-arrhythmia drugs and beta receptor blockaders].
    Mösslacher H
    Wien Med Wochenschr; 1984 Dec; 134(23-24):566-72. PubMed ID: 6152091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac death prevention in post-myocardial infarction patients: a review.
    Boissel JP; Leizorovicz A; Faucomprez C
    Acta Cardiol Suppl; 1980; (25):147-79. PubMed ID: 6103625
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cardiac Arrhythmia Suppression Trial: a disappointment?].
    Magalhães CO
    Arq Bras Cardiol; 1990 Sep; 55(3):153-4. PubMed ID: 2095719
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical trials of antiarrhythmic drugs in postmyocardial infarction and congestive heart failure patients.
    Camm AJ; Yap YG
    J Cardiovasc Pharmacol Ther; 2001 Jan; 6(1):99-106. PubMed ID: 11452341
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of prophylactic antiarrhythmic treatment on the incidence of ventricular arrhythmias in the postinfarction period (author's transl)].
    Wolf R; Sinn R; Guillen R
    Z Kardiol; 1982 Jan; 71(1):26-30. PubMed ID: 6175118
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cardiac arrhythmias in myocardial infarct].
    Lüderitz B; d'Alnoncourt CN
    Internist (Berl); 1980 Nov; 21(11):652-61. PubMed ID: 7005159
    [No Abstract]   [Full Text] [Related]  

  • 12. [Arrhythmia risk stratification in patients with heart failure according to drug treatment and its effects].
    Gronda E; Mangiavacchi M; Andreuzzi B; Municinò A
    Ital Heart J Suppl; 2001 Dec; 2(12):1278-83. PubMed ID: 11838348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of electrophysiology in the prognosis and therapy of cardiomyopathies].
    Laurenzi F; Avella A; Adinolfi E; Dini P
    G Ital Cardiol; 1999 Oct; 29(10):1190-4. PubMed ID: 10546132
    [No Abstract]   [Full Text] [Related]  

  • 14. [Myocardial infarction: secondary prevention with betablockers].
    Depelchin P; Hammoude H; Degré S
    Ann Cardiol Angeiol (Paris); 1989 Mar; 38(3):155-61. PubMed ID: 2567590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Secondary prevention after myocardial infarction].
    Czuriga I
    Orv Hetil; 2002 Sep; 143(37):2117-28. PubMed ID: 12434627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevention and treatment of drug-induced arrhythmia in acute myocardial infarct].
    Steffen V; Fiehring H
    Z Gesamte Inn Med; 1972 Oct; 27(20):875-81. PubMed ID: 4405247
    [No Abstract]   [Full Text] [Related]  

  • 17. [Secondary prevention of myocardial infarct].
    Kotsev G
    Vutr Boles; 1984; 23(2):55-9. PubMed ID: 6146228
    [No Abstract]   [Full Text] [Related]  

  • 18. Ventricular arrhythmias, left ventricular function and mortality after acute myocardial infarction.
    Kulbertus HE
    Eur Heart J; 1986 May; 7 Suppl A():123-6. PubMed ID: 3522235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Management of patients with sustained ventricular arrhythmia: anti-arrhythmia agents or defibrillator?].
    Cappato R; Kuck KH
    Cardiologia; 1996 Feb; 41(2):95-105. PubMed ID: 8674097
    [No Abstract]   [Full Text] [Related]  

  • 20. Beta-blocker effectiveness post infarction: an antiarrhythmic or antiischemic effect.
    Hjalmarson A
    Ann N Y Acad Sci; 1984; 427():101-11. PubMed ID: 6146281
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.